Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Solomon

Showing results (31-40 of 2,270) with videos related to

Pageof 227
Sort By:
Nature Clinical Practice. Cardiovascular Medicine|September 23, 2006
Is elevated cardiovascular risk a class effect of cyclo-oxygenase 2 inhibitors?Scott D Solomon
Alcohol Health and Research World|January 6, 1984
Women in the workplace: an overview of NIAAA's Occupational Alcoholism Demonstration ProjectS D Solomon
Journal of the American College of Cardiology|January 28, 2012
Vasodilators across the heart failure spectrum not all patients, and not all vasodilators, are created equalScott D Solomon
The New England Journal of Medicine|December 24, 1970
Sedimentation rate: normal valuesS D Solomon
Journal of Cataract and Refractive Surgery|January 1, 1995
Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema. Flurbiprofen-CME Study Group IL D Solomon
The CLAO Journal : Official Publication of the Contact Lens Association of Ophthalmologists, Inc|October 1, 1994
Extended wear, corneal hypoxia, and corneal ulcersO D Solomon
Cleveland Clinic Journal of Medicine|May 7, 2002
Chronic tension-type headache: advice for the viselike-headache patientGlen D Solomon
Lancet (London, England)|July 17, 1982
Calcium channel blockers in migraineG D Solomon
Annals of Internal Medicine|December 16, 2015
Gastroesophageal Reflux DiseaseGlen D Solomon
Current Opinion in Cardiology|October 21, 2006
Cyclooxygenase-2 inhibitors and cardiovascular riskScott D Solomon
Pageof 227

Showing results (31-40 of 2,270) with videos related to

Sort By:
Pageof 227
Nature Clinical Practice. Cardiovascular Medicine|September 23, 2006
Is elevated cardiovascular risk a class effect of cyclo-oxygenase 2 inhibitors?Scott D Solomon
Alcohol Health and Research World|January 6, 1984
Women in the workplace: an overview of NIAAA's Occupational Alcoholism Demonstration ProjectS D Solomon
Journal of the American College of Cardiology|January 28, 2012
Vasodilators across the heart failure spectrum not all patients, and not all vasodilators, are created equalScott D Solomon
The New England Journal of Medicine|December 24, 1970
Sedimentation rate: normal valuesS D Solomon
Journal of Cataract and Refractive Surgery|January 1, 1995
Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema. Flurbiprofen-CME Study Group IL D Solomon
The CLAO Journal : Official Publication of the Contact Lens Association of Ophthalmologists, Inc|October 1, 1994
Extended wear, corneal hypoxia, and corneal ulcersO D Solomon
Cleveland Clinic Journal of Medicine|May 7, 2002
Chronic tension-type headache: advice for the viselike-headache patientGlen D Solomon
Lancet (London, England)|July 17, 1982
Calcium channel blockers in migraineG D Solomon
Annals of Internal Medicine|December 16, 2015
Gastroesophageal Reflux DiseaseGlen D Solomon
Current Opinion in Cardiology|October 21, 2006
Cyclooxygenase-2 inhibitors and cardiovascular riskScott D Solomon
Pageof 227